References:
- WHO Classification of Tumors online. (2023) Haematolymphoid Tumours (5th ed.). Available at BlueBooksOnline (who.int) (Accessed 17 August 2023)
- Pulitzer M, Myskowski PL, Horwitz SM, Querfeld C, Connolly B, Li J, Murali R. Mycosis Fungoides with large cell transformation: clinicopathologic features and prognostic factors. Pathology 2014;46(7):610-616.
- Pai, R. K., Mullins, F. M., Kim, Y. H., & Kong, C. S. (2008). Cytologic evaluation of lymphadenopathy associated with mycosis fungoides and Sezary syndrome: role of immunophenotypic and molecular ancillary studies. Cancer, 114(5), 323–332. https://doi.org/10.1002/cncr.23793
- Travaglino A, Russo, D, Varricchio S, Pignatiello S, Baldo A, Picardi M, Pane F, Mascolo M. Prognostic significance of CD30 in transformed mycosis fungoides. A systematic review and meta-analysis. Am J Clin Pathol 2021; 156:350-355.
- Kadin ME, Hughey LC, Wood GS. Large-cell transformation of mycosis fungoides- differential diagnosis with implications for clinical management: A consensus statement of the US Cutaneous Lymphoma Consortium. J Am Acad Dermatol 2014;70:374-6.
- Wu CY, Wang RC, Chen BJ et al. Granuloma with an underlying lymphoma: a diagnostic challenge and a wider histologic spectrum including adult T-cell leukemia/lymphoma. Appl Immunohistochem Mol Morphol 2020;28:316-324.
- Khurana, K.K., Stanley, M.W., Powers, C.N. and Pitman, M.B. Aspiration cytology of malignant neoplasms associated with granulomas and granuloma-like features. Cancer,1998; 84: 84-91. https://doi.org/10.1002/(SICI)1097-0142(19980425)84:2<84::AID-CNCR3>3.0.CO;2-D
- Lucena CMF, Nery NS, Obadia DL, Alves MFGS. Granulomatous mycosis fungoides- A diagnostic challenge. An Bras Dermatol 2015; 90(4):554-6.
- Rosen Y. Pathology of granulomatous pulmonary diseases. Arch Pathol Lab Med 2022; 146:233-251.